logo

Randall Holcombe, MD

Randall Holcombe, MD

Oncology New York, NY

Professor, Medicine, Icahn School of Medicine

Office Address

Office Map
  • 1190 5th Ave
    The Ruttenberg Treatment Ctr
    New York, NY 10029
    Phone: (212) 241-6756
    Fax: (212) 423-0522

Dr. Holcombe's Clinical Specialties & Interests

  • Oncology: General Oncology, Gastrointestinal Cancer

Dr. Holcombe's Education & Medical Training

  • Brigham and Women's HospitalBrigham and Women's HospitalFellowship, Hematology
  • Brigham and Women's HospitalBrigham and Women's HospitalResidency, Internal Medicine
  • Rutgers New Jersey Medical SchoolRutgers New Jersey Medical SchoolMedical School

Dr. Holcombe's Certifications & Licensure

  • NY State Medical LicenseNY State Medical License2010 - 2016
  • MA State Medical LicenseMA State Medical License1986 - 2014
  • CA State Medical LicenseCA State Medical LicenseActive through 2013
  • American Board of Internal MedicineAmerican Board of Internal MedicineInternal Medicine
  • American Board of Internal MedicineAmerican Board of Internal MedicineHematology
  • American Board of Internal MedicineAmerican Board of Internal MedicineMedical Oncology

Dr. Holcombe's Publications & Presentations

PubMed | Citations by Web of Science®

Grant Support

  • Neoadjuvant Photodynamic Immunomodulation For Colon Cancer
    Neoadjuvant Photodynamic Immunomodulation For Colon CancerNational Cancer Institute
    2010 - 2011
  • Patient-Oriented Research: Colon CA &Cancer Immunology
    Patient-Oriented Research: Colon CA &Cancer ImmunologyNational Cancer Institute
    2010 - 2010
  • Phase I Biomarker Study Of Dietary Grape-Derived Low Dose Resveratrol For Colon
    Phase I Biomarker Study Of Dietary Grape-Derived Low Dose Resveratrol For ColonNational Center For Research Resources
    2009 - 2010
  • National Cancer Institute
    2008 - 2008
  • Patient-Oriented Research: Colon CA &Cancer Immunology
    Patient-Oriented Research: Colon CA &Cancer ImmunologyNational Cancer Institute
    2006 - 2010
  • A Phase 1 Study Of CCI-779 In Combination With Imatnib *
    A Phase 1 Study Of CCI-779 In Combination With Imatnib *National Cancer Institute
    2006 - 2006
  • WNT Signaling In Ibd-Related Colon Cancer
    WNT Signaling In Ibd-Related Colon CancerNational Institute Of Diabetes And Digestive And Kidney Diseases
    2004 - 2005
  • Patient Oriented Research--Colon CA &Cancer Immunology
    Patient Oriented Research--Colon CA &Cancer ImmunologyNational Cancer Institute
    2001 - 2005
  • Immunomodulation By Levamisole For Cancer Detection
    Immunomodulation By Levamisole For Cancer DetectionNational Cancer Institute
    1997 - 1997
  • Immunomodulation By Levamisole For Cancer Detection
    Immunomodulation By Levamisole For Cancer DetectionNational Cancer Institute
    1996 - 1996
  • Isolation Of The Gene For Chediak-Higashi Syndrome
    Isolation Of The Gene For Chediak-Higashi SyndromeNational Heart, Lung, And Blood Institute
    1989 - 1993
  • Analysis Of T-Cell Receptor Genes In Red Cell Aplasia
    Analysis Of T-Cell Receptor Genes In Red Cell AplasiaNational Heart, Lung, And Blood Institute
    1986 - 1987

Dr. Holcombe's Professional Memberships

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • BCBS Blue Card PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • Empire BCBS HMO
  • Empire BCBS PPO
  • First Health PPO
  • GHI PPO
  • Great West PPO
  • HIP of New York - Select PPO
  • Humana ChoiceCare Network PPO
  • MagnaCare PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • MVP Healthcare PPO
  • Oxford Health Freedom
  • Oxford Health Liberty
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO

Physicians, view Dr. Holcombe's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV